<<

Ovid: Duane's http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Editores: Tasman, William; Jaeger, Edward A. Título: Duane's Ophthalmology, 2011 Edition Copyright ©2011 Lippincott Williams & Wilkins

> Table of Contents > Duane's Clinical Ophthalmology > Volume 3 > Diseases of the > Chapter 37 - Light Toxicity in the Posterior Segment

Updated 2007.10.01 Chapter 37 Light Toxicity in the Posterior Segment

Stephen G. Schwartz Dan S. Gombos Susan Schneider

It has long been known that light can cause damage to the posterior segment of the eye. What is the nature of solar damage to the eye and how has the notion of light-induced evolved into the concepts recognized today?

Light interaction with the retina can result in various tissue effects. The three ways in which light can damage the posterior segment of the eye are photodisruption, photocoagulation, and phototoxicity.1

Retinal photodisruption is a form of mechanical damage caused by high-powered, ultrashort light exposures, usually nanoseconds to picoseconds in duration. The target tissue is disintegrated and the adjacent tissues are disrupted by shock waves.2 Photodisruption of retinal tissues usually occurs accidentally in conjunction with Q-switched laser use.3

Retinal photocoagulation is a form of thermal damage caused by high-powered, short light exposures, usually between 0.1 and 0.5 seconds in duration.4,5 The target tissue is heated, and the rise in temperature of the affected tissue causes cellular damage, including coagulative necrosis, with subsequent scarring.6 Permanent damage can occur when the temperature is raised by as little as 10°C.1 Photocoagulation of retinal tissues is used clinically, with argon and other lasers. The laser burns produced by these instruments are seen almost immediately.7

Retinal phototoxicity results from a chemical reaction.8 It is caused by low-powered, relatively long light exposures, usually >10 seconds in duration.9 Unlike photodisruption (mechanical) and photocoagulation (thermal), phototoxicity can occur after exposure to a nonlaser light source, such as .1 The light leads to cellular chemical reactions, with subsequent retinal damage.10 The energy required to cause this phototoxic reaction is related to the wavelength of the incident light.11 Phototoxicity occurs at temperatures much below that seen in photocoagulation.10,11,12,13,14 Clinically, the lesion usually is not detected until 24 to 48 hours after the insult.15

Phototoxicity can be divided into photo-oxidative (photochemical) damage and photosensitized reactions. Most toxic reactions discussed here are related to photo-oxidative interactions between incident light and various retinal tissues.1 Photosensitized reactions include photodynamic reactions, such as used therapeutically in photodynamic therapy with verteporfin (Visudyne, Novartis, Basel, Switzerland) for exudative age-related (AMD).16

History Light-induced retinal damage has been recognized at least since the time of Plato.17 Galileo reportedly sustained retinal toxicity while using a telescope for solar observation.18

1 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

In 1912, Birch-Hirschfeld suggested that eclipse blindness was caused by visible light.19 Verhoeff and Bell opposed this explanation and, in 1916, proposed that solar retinopathy resulted from thermal damage rather than from the photochemical effects of light.20 In 1962, Vos, using mathematical models, estimated that the temperature rise in the retina during exposure to light in cases of eclipse blindness was only about 2 degrees higher than ambient temperature.21 Similarly, Noell et al. proposed a nonthermal phototoxic mechanism for light-induced retinal damage.22

In the mid-1970s, Cain et al. used thermocouple probes to demonstrate that solar retinopathy occurred from photochemical damage (phototoxicity) rather than from thermal damage (photocoagulation).23,24

In 1983, McDonald and Irvine reported the first cases of iatrogenic phototoxicity in patients who had undergone uncomplicated surgery.8 In 1986, Robertson and Feldman established a cause- and-effect relation between the operating room microscope and retinal phototoxicity.25 Since then, numerous publications on iatrogenic phototoxicity have appeared, describing cases associated with cataract surgery,26,27,28,29,30,31,32 other anterior segment procedures,33,34 and pars plana vitrectomy (PPV).35,36,37

Protective Mechanisms The retina is protected from light toxicity through a variety of adaptations, including physical barriers (eyebrow ridge)38 and various reflexes (squint reflex, blink reflex, and ).39 Retinal xanthophyll and melanin pigments may offer additional protection,40,41,42 possibly by converting light to heat, and by suppressing free radicals and photosensitized molecules.12,43 The constant turnover and renewal of rod and cone outer segment discs may also blunt the effects of light toxicity.44 Various biochemical pathways may scavenge toxic molecules, such as superoxide, hydrogen peroxide, hydroxyl radical, and singlet oxygen.45

The wavelength and intensity of light that can be transmitted through the ocular media determine the potential for light-induced retinal damage.46 The wavelength of visible light ranges from 400 to 700 nm.47 (UV; 100 to 400 nm) and infrared (from 700 to >10,000 nm) light represent nonvisible light adjacent to the extremes of the visible spectrum, and these, as well as the visible spectrum, are capable of interacting with the eye.1

The reflects most of the light not perpendicular to its surface and absorbs incident light in the UV-C (100 to 260 nm), UV-B (260 to 315 nm), and infrared (>700 nm) ranges. The absorbs most of the light in the UV-A (315 to 400 nm) range and some UV-B and near infrared light.1,27,48 Its filtering action varies with age-related changes in lens proteins.49 With aging, the lens provides increasing amounts of protection from shorter wavelengths. The aqueous humor absorbs some UV-B, UV-A, and infrared light,50 whereas the vitreous absorbs light in the range of up to 300 nm and some infrared light.51 Early poly(methylmethacrylate) (PMMA) intraocular lenses (IOL) transmitted UV and visible light.1,52 Since 1986, most IOL designs have blocked UV wavelengths.52

The net result is that the ocular media allow transmission of light with wavelengths between about 400 and 1,400 nm (Fig. 3-37.1).46,49,53,54 Of particular concern are the violet (400 to 440 nm) and blue (440 to 500 nm) wavelengths.

2 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Figure 3-37.1. A comparison of the transmittance through the ocular media (cornea, aqueous, lens, and vitreous) and the wavelength (nm) as measured for 32 human eyes, nine rhesus monkey eyes, and 48 rabbit eyes. (From Ham WT, Mueller HA, Ruffulo JJ et al: Solar retinopathy as a function of wavelength: Its significance for protective eyewear. In Williams TP, Baker BN [eds]: The effects of Constant Light on Visual Processes. New York: Plenum Press, 1980:319–346, with permission.)

Risk Factors In general, the four most important factors in determining biological tissue response to light exposure are the size of the area affected (optical zone), the wavelength of incident light, the duration of exposure, and the total energy exposure.1 With regard to the retina, two important exceptions to this general principle exist, both of which are related to the unique light-focusing properties of the anterior segment of the eye. First, the optical zone is typically limited to the macula, so in effect the most important factors are wavelength, intensity, and duration.4,55,56,57,58,59,60,61 Second, a light exposure insufficient to cause damage to any other part of the body can cause significant damage to the macula.1

Photochemical (phototoxic) damage is generally caused by shorter wavelengths of visible light. The most potentially toxic wavelengths are in the near-UV (320 to 400 nm) and short wavelength visible (400 to 500 nm) light ranges.62,63 In contrast, thermal injury (photocoagulation) is generally caused by longer wavelengths.64,65

Additional risk factors for phototoxicity, demonstrated in various experimental models, include increased

3 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

core temperature66,67 elevated blood oxygen levels,12,42,68,69 and the lipofuscin constituent A2E.70 Potential clinical risk factors include diabetes mellitus28 and use of hydrochlorothiazide,28,71 St. John's wort,74 and perhaps certain IOL designs.9

Clinical Manifestations Posterior segment light toxicity is probably under reported, because many cases are asymptomatic and objective signs may be subtle. The macular changes may be more evident on angiography than clinically (Fig. 3-37.2)

Figure 3-37.2. A: Fluorescein angiography of a 49-year-old patient with a malignant melanoma on the left who consented to deliberate induction of by the operating microscope before scheduled enucleation of that eye. Red-free photograph of the normal posterior pole of the left eye pre-exposure. B: Late phase of the angiogram, pre-exposure, demonstrates a normal macula. C: Red-free photograph of the left eye after light exposure showing a vertically oriented lesion centered in the macula. D: Late phase of the angiogram demonstrates hyperfluorescence in the area of photic damage. (From Green WR, Robertson DM: Pathologic findings of photic retinopathy in the . Am J Ophthalmol 112:520, 1991, with permission.)

Phototoxicity can be divided into three phases: acute, reparative, and chronic degenerative.15

Immediately after exposure, there may be no obvious sign of disease. A temporary blood–retinal barrier dysfunction may be detected by fluorophotometry, however.75 The first clinically apparent signs are typically mild pigmentary changes, retinal edema, or both, usually within 24 to 48 hours.15 The pigmentary changes may become more visible over the first week. After the first month, the lesions generally become smaller, to a variable degree.15,76,77 Chronic decompensation of the blood–retinal barrier can occur over years.7

Light-induced retinal damage can be permanent,22 but typically improves to a variable extent.42 In general, the prognosis is fairly good.30,31,78,79 Important prognostic factors include the size and location of the lesion.7,36 Secondary choroidal neovascularization can develop.78,80

4 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

The clinical syndromes can be separated into those attributed to ambient light and those to iatrogenic causes.

Solar Retinopathy Solar retinopathy has been recognized for centuries, under the terms eclipse blindness, photoretinitis, photomaculopathy, and foveomacular .81,82,83,84,85 Solar retinopathy has been described in military personnel, sun bathers, religious sun gazers, solar eclipse viewers, and people under the influence of psychotropic drugs.86 Solar retinopathy is typically photochemically mediated (phototoxic), but can be enhanced by thermal effects (photocoagulation).87

Typically, symptoms begin several hours after exposure and can include periorbital ache, decreased vision, metamorphopsia, chromatopsia, central or paracentral scotomata, and afterimages. Visual acuity may be reduced to 20/200, but may return to 20/40 or better within 4 to 6 months.88,89 The associated symptoms can persist indefinitely.

A small, yellowish foveal lesion may be seen in the acute phase, which corresponds to the retinal image of the sun, approximately 160 μm in diameter.87 As the lesion fades, it usually is replaced by a lamellar hole and may show a corresponding window defect on fluorescein angiography. Alternatively, the angiogram could be normal.

Welder's arc exposure is typically associated with ; however, retinal damage can occur.90 Clinically, welder's maculopathy is similar to solar retinopathy.91,92 Macular hole formation can occur in severe cases.93

Operating Microscope Toxicity Operating microscope toxicity was suggested in 1977,94 with the first cases reported in 1983.8,95 Since then, this entity has become commonly recognized25,26,27,28,29,30,31,32,96,97,98 and is associated with various surgical procedures (Fig. 3-37.3).39,40,41,99,100,101 The first apparent report of phototoxicity during cataract surgery in a pediatric patient was published in 2004.102 The incidence of reported cases, specifically of iatrogenic causes of retinal phototoxicity, vary between retrospective and prospective studies.28,32,36,98,103

5 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Figure 3-37.3. A: Fundus photograph of a 58-year-old patient 1 week after uncomplicated cataract extraction with posterior chamber intraocular lens placement in the left eye utilizing a temporal clear corneal incision. The photograph demonstrates an elliptical area of pigment mottling with a yellow-white appearance at the level of the outer retina (small arrows) and with an overlying neurosensory (curved arrows). B: Red-free photograph of the same patient shows a lighter appearing elliptical area (arrows) at the level of the outer retina. C: Transit phase of the angiogram demonstrates a sharply circumscribed elliptical area of mottled hyper- and hypofluorescence at the level of the retinal pigment epithelium. D: Late phase of the angiogram demonstrates progressive hyperfluorescence and accumulation of dye in the neurosensory detachment. (From Dick JSB II, Bressler SB: Unusual case of postoperative phototoxic maculopathy. The Wilmer Retina Update 4:58, 1998, with permission.)

In general, the shape and size of the retinal lesion caused by the operating room microscope are dependent on the light source or filament used and the orientation of the illuminator.28 The shape of the macular lesion may correspond with the shape of the microscope light source.28,59

The surgeon's view through the microscope is that of diffuse, even light through one illumination source. The retina of the operative eye, however, is exposed focally to illumination from side sources of light.59 By design, most operating microscopes are not absolutely coaxial, so the illumination and viewing systems are not necessarily in line. The increasing popularity of topical anesthesia, with the surgeon's instructions that the patient fixate on the light source, may increase the risk.59

Endoilluminator Toxicity A related toxicity is associated with various endoilluminator probes used during PPV (Fig. 3-37.4).36,78,104,105 As compared with traditional halogen or metal halide light sources, the newer xenon light sources emit light at higher intensity and shorter wavelengths. They are typically used with a

6 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

bandpass filter to reduce UV transmission.106,107 In a recent experimental model, the xenon/bandpass light showed comparable toxic potential to halogen light.108

Figure 3-37.4. A: Fundus photograph of a patient after macular hole surgery in the left eye. Partial closure of the macular hole resulted in more severe light-induced toxicity in the temporal macula, where the hole was closed. B: Arteriovenous phase of a fluorescein angiogram of the same patient shows a corresponding area of mottled hyper- and hypofluorescence. (Courtesy of Jay S. Duker, MD, Boston, MA.)

The increasing popularity of indocyanine green (ICG) dye to stain internal limiting membrane,109 ,110 and other structures during PPV raises other potential concerns about toxicity. The absorption spectrum of ICG overlaps with the emission spectra of common endoilluminators,107,110 and a cumulative toxicity between ICG and an 805-nm diode laser has been noted in other experimental systems.111,112 Recent experimental models of ICG-mediated phototoxicity have reported conflicting results.113,114,115,116 The incidence of clinical toxicity, however, appears low at this time.117

Possible Associations Many other diseases, which are multifactorial in etiology, may include some contribution from phototoxicity. In most cases, the precise mechanisms are poorly understood and the associations are unproved.

Age-Related Macular Degeneration A possible link between ambient light exposure and AMD was initially proposed in 1920.118 More recently, the possible protective effects of nuclear sclerotic cataract119 and ocular pigmentation120,121,122,123,124,125,126,127,128,129 have been noted. Epidemiologic studies on the association between ambient light exposure and AMD have reported conflicting results.130,131,132,133,134,135,136,137,138

Similarly, an unproved potential association exists between cataract surgery and advanced AMD.139 Recently, it was proposed that some of this association may be caused by operating microscope phototoxicity.140

Retinopathy of Prematurity Retinopathy of prematurity (ROP) has many risk factors, primarily supplemental oxygen therapy.141 Theoretically, light exposure may play a role142,143,144 through the generation of free radicals in the retina.145,146,147,148

7 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

The LIGHT-ROP study,144 in which researchers randomized >400 infants with birth weights <1,251 g and gestational ages <31 weeks to exposure to normal nursery conditions versus wearing that reduce visible light and UV light, reported that ambient light did not affect the incidence of ROP in their study population.

Cystoid A possible contributing effect of the operating microscope to postoperative cystoid macular edema (CME) has been proposed.94,149,150

Multiple studies have failed to demonstrate an association between UV filters on the operating microscope and CME.151,152 Conflicting results regarding the benefit of UV-blocking IOL designs have been reported.153,154 The operating room microscope emits little light in the UV range, however, and further investigation may be warranted into other wavelengths of light, such as visible blue.

Uveal Melanoma The increased incidence of uveal melanoma among the white population has led some to theorize a racial predisposition related to the oncologic effects of sunlight.155 Some studies have demonstrated higher rates of uveal melanoma among susceptible populations, such as those living in Australia.156,157 Other reports suggest an occupational risk among those exposed to intense UV, including welders.158,159,160 Additional studies and a meta-analysis of over 133 published reports, however, have yielded inconsistent results and no clear association between sun and UV light exposure with the development of uveal melanoma.161,162,163

Pathologic Findings Clinicopathologic correlations of photic retinopathy have been reported by several investigators.15,76,77,164,165,166 An animal model of phototoxicity was developed using an indirect ophthalmoscope.75 Significant changes were produced the first week after exposure, but a distinct maculopathy became evident only after an extended follow-up (5 months). The authors described three stages: initial degeneration in the first week, macrophagic response between the first week and first month, and repair and regeneration between the first and fifth month. Regeneration of photoreceptors was noted over proliferating retinal pigment epithelial (RPE) cells.

Histopathologic study of photic retinopathy in the human eye caused by exposure to light from the operating room microscope was reported in 1991.164 A patient with an iris malignant melanoma, scheduled for enucleation, consented to exposure to an operating microscope for 60 minutes (Figs. 3-37.5,3-37.6,3-37.7,3-37.8). The enucleation was perfomed 72 hours after light exposure. Findings occurred mainly at the level of the RPE and photoreceptor layer and included localized necrosis of the RPE; loss of the apical villi, plasma membranes, and cytoplasmic organelles of the RPE cells; extrusion of the retinal pigment epithelial pigment granules; and extensive disruption of the outer lamellae of the photoreceptors. Swollen mitochondria were present within the photoreceptor inner segments. Although this study was designed to address the issue of acute light-induced retinal damage, the additional finding of thinned RPE cells, which apparently had migrated under injured RPE cells, suggests that a reparative process had already begun.

8 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Figure 3-37.5. Light-microscopic appearance of an area of junction between phototoxic lesion (to the right) and normal unaffected retina and retinal pigment epithelium (to the left). In the lesion, the retina is edematous. An amorphous material is observed in the area of disrupted outer segments of the photoreceptors and the subretinal space. (From Green WR, Robertson DM: Pathologic findings of photic retinopathy in the human eye. Am J Ophthalmol 112:520, 1991, with permission.)

9 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Figure 3-37.6. Light-microscopic appearance of photic retinopathy with edematous outer retina and the edematous irregularly thickened retinal pigment epithelium. Most of the swelling involves the photoreceptor layer where an amorphous material largely replaces the outer segments. The photoreceptor nuclei appear relatively intact. (From Green WR, Robertson DM: Pathologic findings of photic retinopathy in the human eye. Am J Ophthalmol 112:520, 1991, with permission.)

10 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Figure 3-37.7. Electron-microscopic view of photic retinopathy with extensive derangement of the outer segments of the photoreceptors with distention (main figure), distortion, compaction, partial disintegration of the lamellar disks, and disruption of plasma membranes. The inner segments of the cones are moderately swollen and the mitochondria are markedly distended. Inset shows details of the swollen mitochondria. (From Green WR, Robertson DM: Pathologic findings of photic retinopathy in the human eye. Am J Ophthalmol 112:520, 1991, with permission.)

11 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Figure 3-37.8. Electron-microscopic view of photic retinopathy. The retinal pigment epithelial cells are severely damaged with loss of plasma membranes, apical villous processes, basal infoldings, and extrusion of pigment granules. Overlying the retinal pigment epithelial cells, a variably dense granular material containing fragments of outer segments is observed. (From Green WR, Robertson DM: Pathologic findings of photic retinopathy in the human eye. Am J Ophthalmol 112:520, 1991, with permission.)

Similar microscopic findings were reported in studies of sun-exposed human eyes.151 This similarity suggests a common mechanism between damage from ambient light or iatrogenic sources.

Prevention Because the basic mechanisms and risk factors involved in retinal phototoxicity are now well understood, many forms of prevention are self-evident.

Public awareness of potential damage is paramount, and may reduce the risk of toxicity from sun gazing, observation of solar eclipses, and welding arcs.

Sunglasses have an important role in preventing light damage. Ophthalmologists should counsel patients with specific risk factors, such as aphakic patients167,168 and some pseudophakic patients, especially those with non–UV-absorbing IOL designs.2,167 A recent report recommended, however, that all pseudophakic patients wear in bright environments.169 Other patients who may be at risk include those receiving any form of photosensitizing medication (including verteporfin),71,170 infants and children with clear ocular media,48 malnourished people or those with malabsorption syndromes,171 and, although unproved, individuals at risk for AMD.

Standards for sunglasses have been established by the American National Standards Institute,172 but

12 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

enforcement may be ineffective in certain cases.173,174 Sunglass design must take into account a balance between phototoxicity protection and the maintenance of good vision with comfortable color perception.39 All of the wavelengths >700 nm and <400 nm can be filtered out without having an impact on visual performance, but certain compromises must be made regarding light in the 400- to 500-nm light range. Filtering out all wavelengths <500 nm would eliminate 98% of risk for retinal phototoxicity,39 but blocking wavelengths between 400 and 500 nm yields a yellow hue to the vision, which is poorly tolerated. Therefore, these wavelengths of light may need to be attenuated rather than eliminated. Ideally, filtration should apply to all forms of optical devices, including spectacles, contact lenses, goggles, IOL, and diagnostic and surgical instruments (Fig. 3-37.9).

Figure 3-37.9. Transmittance versus wavelength in nanometers for the aphakic Rhesus monkey ocular media, with and without an ideal lens. Curve a, transmittance through cornea, aqueous, and vitreous, curve b, transmittance through an ideal lens that in combination with curve a produces 0.0 transmittance <400 nm, 0.2 transmittance at 440 nm, 0.5 at 480 nm, and 0.0 >750 nm; curve c, transmittance through entire ocular media including cornea, aqueous ideal lens, and vitreous. (Based on data from Maher EF: Transmission and absorption coefficients for ocular media of the rhesus monkey. Report SAM-TR-78-32. Brook Air Force Base, Texas, US Air Force School of Aerospace Medicine, 1978.)

Some authors have advocated blue-blocking, as well as UV-blocking, IOL materials.180 Other authors have proposed, however, that this will interfere with scotopic vision in elderly patients.181

Preventing iatrogenic retinal phototoxicity is more complex. Light-induced retinal damage is mostly caused

13 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

by wavelength, exposure time, and power.4,60,61 In the operating microscope, the selective use of filters to block unneeded wavelengths of light without compromising the surgeon's view may aid in the prevention of light-induced injury. In addition, by eliminating light in the infrared range, thermal enhancement of potential phototoxic damage might be reduced. Many currently available microscopes contain an internal opaque filter to shield the pupillary aperture, which can be used during parts of a procedure in which intraocular manipulation or visualization of a red reflex is not required. Alternatively, a piece of microsurgical sponge or other opaque material can be placed on the cornea over the visual axis. Nevertheless, iatrogenic retinal phototoxicity has been reported despite these precautions.79

The surgeon should reduce the intensity of the operating microscope to the level needed for adequate visualization. Halving the illumination intensity results in a doubling of the threshold time to a phototoxic lesion.59 Oblique illumination can be used during a case when coaxial lighting is not needed.7,60

Exposure time should be limited as much as practicable, including the use of opaque shields over the visual axis during appropriate parts of the procedure.175,176,177,178 Phototoxicity can occur in as little as 4 to 10 minutes.59 Therefore, although the total length of the procedure is important, the key factor is the time that the operating room microscope is focused on one set location of the retina. It has been estimated that, during cataract surgery, the surgeon is not looking through the oculars for up to 20% of the procedure,179 so the illumination could be decreased during these periods. Additionally, microscope tilt or infraduction of the can displace the area of maximal illumination and, therefore, place the potential site of phototoxicity outside of the fovea.63

During pars plana vitrectomy, the endoilluminator presents an additional source of potential phototoxicity,36,37 and surgeons should attempt to minimize the incident light on the fovea.

Using the above discussed techniques, the incidence of phototoxicity may be reduced, but the most important step is to maintain a high level of suspicion regarding the potential danger of light toxicity to a patient's eye.

References

1. Glickman RD: Phototoxicity to the retina: Mechanisms of damage. Int J Toxicol 21:437–490, 2002

2. Mainster MA, Ham WT Jr, Delori FC: Potential retinal hazards: Instrument and environmental light sources. Ophthalmology 90:927, 1983

3. Thach AB, Lopez PF, Snady-McCoy LC et al: Accidental Nd:YAG laser injuries to the macula. Am J Ophthalmol 119:767, 1995

4. Ham WT Jr, Ruffolo JJ Jr, Mueller HA et al: The nature of retinal radiation damage: Dependence on wavelength, power level and exposure time. Vis Res 20:1105, 1980

5. Mainster MA, White TJ, Tips JH, Wilson PW: Retinal-temperature increases produced by intense light sources. J Opt Soc Am 60:264, 1970

6. Mainster MA: Wavelength selection in macular photocoagulation: Tissue optics, thermal effects, and laser systems. Ophthalmology 93:952, 1986

7. Michels M, Sternberg P Jr: Operating microscope-induced retinal phototoxicity: Pathophysiology, clinical manifestations and prevention. Surv Ophthalmol 34:237, 1990

8. McDonald HR, Irvine AR: Light-induced maculopathy from the operating microscope in

14 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

extracapsular cataract extraction and intraocular lens implantation. Ophthalmology 90:945, 1983

9. Ham WT Jr, Mueller HA, Ruffolo JJ Jr et al: Sensitivity of the retina to radiation damages as a function of wavelength. Photochem Photobiol 29:735, 1979

10. Mainster MA: Finding your way in the photoforest: Laser effects for clinicians. Ophthalmology 91:886, 1984

11. Ham WT Jr, Mueller HA, Sliney DH: Retinal sensitivity to damage from short wavelength light. Nature 260:153, 1976

12. Ham WT Jr, Mueller HA, Ruffolo JJ Jr et al: Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res 3:165, 1984

13. Lawhill T: Three major pathologic processes caused by light in the primate retina: A search for mechanisms. Trans Am Ophthalmol Soc 80:517, 1982

14. Noell WK: Possible mechanisms of photoreceptor damage by light in mammalian eyes. Vision Res 20:1163, 1980

15. Tso MOM: Photic maculopathy in rhesus monkeys: A light and electron microscopic study. Invest Ophthalmol Vis Sci 12:17, 1973

16. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group: Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials—TAP report. Arch Ophthalmol 117:1329–1345, 1999

17. Duke-Elder S, MacFaul PA: Radiational injuries. In Duke-Elder S (ed): System of Ophthalmology, Vol. XIV. St. Louis, MO: Mosby, 1972:837–1010

18. Sliney DH, Wolbarsht ML: Safety with Lasers and Other Optical Sources. New York: Plenum Publishing, 1980

19. Birch-Hirschfeld A: Zum Kapitel der sonnenblendung des auges. Z Augenheilkd 28:324, 1912

20. Verhoeff FH, Bell L: The pathological effects of radiant energy on the eye. Proc Am Acad Arts Sci 51:630, 1916

21. Vos JJ: A theory of retinal burns. Bull Math Biophys 24:115, 1962

22. Noell WK, Walker VS, Kang BS et al: Retinal damage by light in rats. Invest Ophthalmol 5:450, 1966

23. Cain CP, Welch AJ: Measured and predicted laser induced temperature rise in the rabbit fundus.

15 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Invest Ophthalmol 13:60, 1974

24. Priebe LA, Cain CP, Welch AJ: Temperature rise required for the production of minimal lesions in the macaca mulatta retina. Am J Ophthalmol 79:405, 1975

25. Robertson DM, Feldman RB: Photic retinopathy from the operating room microscope. Am J Ophthalmol 101:561, 1986

26. DeLaey JJ, DeWachter A, VanOye R et al: Retinal phototrauma during intraocular lens implantation. Int Ophthalmol 7:109, 1984

27. Khwarg SG, Geoghegan M, Hanscom TA: Light induced maculopathy from the operating microscope. Am J Ophthalmol 98:628, 1984

28. Khwarg SG, Linstone FA, Daniels SA et al: Incidence, risk factors and morphology in operating microscope light retinopathy. Am J Ophthalmol 103:255, 1987

29. Berler DK, Peyser R: Light intensity and visual acuity following cataract surgery. Ophthalmology 90:933, 1983

30. Boldrey EE, Ho BT, Griffith RD: Retinal burns occurring at cataract extraction. Ophthalmology 91:1297, 1984

31. Lindquist TD, Grutzmacher RD, Gofman JD: Light-induced maculopathy: Potential for recovery. Arch Ophthalmol 104:1641, 1986

32. Byrnes GA, Antoszyk AN, Mazur DO et al: Photic maculopathy after extracapsular cataract surgery: A prospective study. Ophthalmology 99:731, 1992

33. Stamler JF, Blodi CF, Verdier D et al: Microscope light-induced maculopathy in combined penetrating keratoplasty, extracapsular cataract extraction, and intraocular lens implantation. Ophthalmology 95:1142, 1988

34. Cech JM, Choromokose EA, Sanitato JA: Light induced maculopathy following penetrating keratoplasty and intraocular lens implantation. Arch Ophthalmol 105:751, 1987

35. McDonald HR, Harris MJ: Operating microscope induced retinal phototoxicity during pars plana vitrectomy. Arch Ophthalmol 106:521, 1988

36. Michels M, Lewis H, Abrams GW et al: Macular phototoxicity caused by fiberoptic endoillumination during pars plana vitrectomy. Am J Ophthalmol 114:287, 1992

37. Kuhn F, Morris R, Massey M: Photic retinal injury from endoillumination during vitrectomy. Am J Ophthalmol 111:42, 1991

38. Azzolini C, Brancato R, Venturi G et al: Updating on intraoperative light-induced retinal injury. Int

16 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Ophthalmol 18:269, 1995

39. Sliney DH: Eye protective techniques for bright light. Ophthalmology 90:937, 1983

40. Snodderly DM, Auran JD, Delori FC: The macular pigment. II. Spatial distribution in primate . Invest Ophthalmol Vis Sci 25:674, 1984

41. Kirschfeld K: Carotenoid pigments. Their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc R Soc Lond B Biol Sci 216:71, 1982

42. Jaffe GJ, Wood I: Retinal phototoxicity from the operating microscope: Protective effect by the fovea. Arch Ophthalmol 106:445, 1988

43. Rapp LM, Williams TP: The role of ocular pigmentation in protecting against retinal light damage. Vision Res 20:127, 1980

44. Young RW: The Bowman Lecture: Biological renewal: Applications to the eye. Trans Ophthalmol Soc UK 102:42, 1982

45. Fridovich I: Oxygen radicals, hydrogen peroxide, and oxygen toxicity. In Pryor WA (ed): Free Radicals in Biology. New York: Academic Press, 1976:239–277

46. Mayer EF: Transmission and absorption coefficients for ocular media of the rhesus monkey, report SAM-TR-78-32. Brook Air Force Base, TX: USAF School of Aerospace Medicine, 1978

47. Weast RC (ed): CRC Handbook of Chemistry and Physics: A Ready Reference Book of Clinical and Physical Data. Boca Raton, FL: CRC Press, 1984:184

48. Boettner EA, Wolter JR: Transmission of ocular media. Invest Ophthalmol Vis Sci 1:776, 1962

49. Lerman S: Chemical and physical properties of the normal and aging lens: Spectroscopic (UV, fluorescence, phosphorescence and NMR) analyses. Am J Optom Physiol Optics 64:11, 1987

50. Brancato R, Pratesi R: Application of diode laser in ophthalmology. Laser Ophthalmol 1:119, 1987

51. Azzolini C, Docchio F, Brancato R et al: Interactions between light and vitreous fluid substitutes. Arch Ophthalmol 110:1468, 1992

52. Mainster MA: The spectra, classification, and rationale of ultraviolet-protective intraocular lenses. Am J Ophthalmol 102:727–732, 1986

53. Ham WT, Mueller HA, Ruffolo JJ et al: Solar retinopathy as a function of wavelength: Its significance for protective eyewear. In Williams TP, Baker BN (eds): The Effects of Constant Light on Visual Processes. New York: Plenum Press, 1980: 319–346

17 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

54. Geeraets WJ, Berry ER: Ocular spectral characteristics as related to hazards from laser and other light sources. Am J Ophthalmol 66:15, 1968

55. Lawhill T, Crockett S, Currier G: Retinal damage secondary to chronic light exposure, thresholds and mechanisms. Doc Ophthalmol 44:379, 1977

56. Irvine AR, Wook I, Morris AW: Retinal damage from the illumination of the operating microscope: An experiment and study in pseudophakic monkeys. Arch Ophthalmol 102:1358, 1984

57. Colvard DM: Operating microscope light-induced retinal injury: Mechanisms, clinical manifestation and preventive measures. Am Intraocular Implant Soc J 10:438, 1984

58. Griess GA, Blankenstein MF: Additivity and repair of actinic retinal lesions. Invest Ophthalmol Vis Sci 20:803, 1981

59. Irvine AR: Retinal complications of cataract surgery. In Freeman WR (ed): Practical Atlas of Retinal Disease and Therapy. Philadelphia: Lippincott-Raven, 1998:155–161

60. Davidson PC, Sternberg P Jr: Potential retinal phototoxicity. Am J Ophthalmol 116:497, 1993

61. Cowan CL: Light hazards in the operating room. J Natl Med Assoc 84:425, 1992

62. Flynn HW, Brod RD: Protection from operating microscope-induced retinal phototoxicity during pars plana vitrectomy. Arch Ophthalmol 106:1032, 1988

63. Brod RD, Olson KR, Ball SF et al: The site of operating microscope light induced injury on the human retina. Am J Ophthalmol 207:390, 1989

64. Ham WT, Ruffolo JJ, Mueller HA et al: Action spectrum of retinal injury from near UV radiation in the aphakic monkey. Am J Ophthalmol 93:299, 1982

65. Lawhill T: Effects of prolonged exposure of rabbit retina to low intensity light. Invest Ophthalmol Vis Sci 12:45, 1973

66. Friedman E, Kuwabara T: Retinal pigment epithelium: Damaging effects of radiant energy. Arch Ophthalmol 80:265, 1968

67. Rinkoff J, Machemer R, Hida T et al: Temperature dependent light damage to the retina. Am J Ophthalmol 102:452, 1986

68. Lanum J: The damaging effects of light on the retina: Empirical findings, theoretical and practical implications. Surv Ophthalmol 22:221, 1978

69. Parver LM, Ham WT, Mitchard et al: Arterial oxygen levels as a risk factor for photochemical

18 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

retinal damage in the surgical eye patient. Opthalmology 91(Suppl): 135, 1984

70. Yanagi Y, Inoue Y, Jang WD, Kadonosono K: A2e-mediated phototoxic effects of endoilluminators. Br J Ophthalmol 90:229–232, 2006

71. Roberts JE, Reme CE, Dillon J et al: Exposure to bright light and the concurrent use of photosensitizing drugs. N Engl J Med 326:1500, 1992

72. Becker, L, Eberlein-Konig B, Przybilla B: Phototoxicity of non-steroidal anti-inflammatory drugs: In vitro studies with visible light. Acta Derm Venereol 76:337–340, 1996

73. Bagheri H, Lhiaubet V, Montastruc JL, Chouini-Lalanne N: Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data. Drug Saf 22:339–349, 2000

74. Schey KL, Patat S, Chignell CF et al: Photooxidation of lens α-crystallin by hypericin (active ingredient in St. John's wort). Photochem Photobiol 72:200–203, 2000

75. Borsje RA, Vrensen GF, van Best JA et al: Fluorophotometric assessment of blood-retinal barrier function after white light exposure in the rabbit eye. Exp Eye Res 50:297, 1990

76. Tso MOM, Fine B, Zimmerman L: Photic maculopathy produced by the indirect ophthalmoscope. Am J Ophthalmol 73:686, 1972

77. Tso MOM, Woodward BJ: Effect of photic injury on the retinal tissues. Ophthalmology 90:952, 1983

78. Postel EA, Pulido JS, Byrnes GA et al: Long-term follow-up of iatrogenic phototoxicity. Arch Ophthalmol 116:753, 1998

79. Hupp SL: Delayed, incomplete recovery of macular function after photic retinal damage associated with extracapsular cataract extraction and posterior lens insertion. Arch Ophthalmol 105:1022, 1987

80. Leonardy NJ, Dabbs CK, Sternberg P Jr: Subretinal neovascularization after operating microscope burn. Am J Ophthalmol 109:224, 1990

81. Cordes FC: A type of foveomacular retinitis observed in the US Navy. Am J Ophthalmol 27:803, 1944

82. Ewald RA, Ritchey CL: Sun gazing as the cause of foveomacular retinitis. Am J Ophthalmol 70:491, 1970

83. Kerr LM, Little HL: Foveomacular retinitis. Arch Ophthalmol 76:498, 1966

84. Marlor RL, Blais BR, Preston FR et al: Foveomacular retinitis, an important problem in military

19 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

medicine: Epidemiology. Invest Ophthalmol Vis Sci 12:5, 1973

85. Wergeland FL Jr, Brenner EH: Solar retinopathy and foveomacular retinitis. Ann Ophthalmol 7:495, 1975

86. Yannuzzi LA, Fisher YL, Krueger A et al: Solar retinopathy: A photobiological and geophysical analysis. Trans Am Ophthalmol Soc 85:120, 1987

87. White TJ, Mainster MA, Wilson PW et al: Chorioretinal temperature increases from solar observation. Bull Math Biophys 33:1, 1971

88. Penner R, McNair JN: Eclipse blindness. Am J Ophthalmol 61:1452, 1966

89. Hatfield EM: Eye injuries and the solar eclipse. Sight Saving Rev 40:79, 1970

90. Naidoff MA, Sliney DH: Retinal injury from a welding arc. Am J Ophthalmol 77:663, 1974

91. Romanchuk KG, Pollak V, Schneider RJ: Retinal burn from a welding arc. Can J Ophthalmol 13:120, 1978

92. Uniat L, Olk RJ, Hanish SJ: Welding arc maculopathy. Am J Ophthalmol 102:394, 1986

93. Wurdemann HV: The formation of a hole in the macula: Light burn from exposure to electric welding. Am J Ophthalmol 19:457, 1936

94. Henry MM, Henry LM, Henry LM: A possible cause of chronic cystic maculopathy. Ann Ophthalmol 9:455, 1977

95. Macy JI, Baerveldt G: Pseudophakic serous maculopathy. Arch Ophthalmol 101:228, 1983

96. Fishman GA: Light-induced maculopathy from surgical microscopes during cataract surgery. In Ernest JT (ed): 1985 Year Book of Ophthalmology. Chicago: Year Book Medical Publishers, 1985:177–181

97. Byrnes GA, Chang B, Loose I et al: Prospective incidence of photic maculopathy after cataract surgery. Am J Ophthalmol 119:231, 1995

98. Gomolin JES, Koenekoop RK: Presumed photic retinopathy after cataract surgery: An angiographic study. Can J Ophthalmol 28:221, 1993

99. Brod RD, Barron BA, Suelflow JA et al: Phototoxic retinal damage during refractive surgery. Am J Ophthalmol 102:121, 1986

100. Kramer T, Brown R, Lynch M et al: Molteno implants and operating microscope-induced retinal

20 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

phototoxicity: A clinicopathologic report. Arch Ophthalmol 109:379, 1991

101. Rouland JF, Constantinides G, Turut P: Light-induced maculopathy following epikeratoplasty. Refractive Corneal Surg 6:270, 1990

102. Long VW, Woodruff GH: Bilateral retinal phototoxic injury during cataract surgery in a child. J AAPOS 8:278–279, 2004

103. Kelly NE, Wendell RT: Vitreous surgery for idiopathic macular holes: Results of a pilot study. Arch Ophthalmol 109:654, 1991

104. McDonald HR, Verre WP, Aaberg TM: Surgical management of idiopathic epiretinal membranes. Ophthalmology 93:978–983, 1986

105. Banker AS, Freeman WR, Kim JW et al: Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology 104:1442–1452, 1997

106. Vander JF, Eagle RC Jr, Brown GC et al: Retinal tolerance of an implantable light source for use during vitrectomy surgery. Ophthalmic Surg 22:735–379, 1991

107. van den Biesen PR, Berenschot T, Verdaasdonk RM et al: Endoillumination during vitrectomy and phototoxicity thresholds. Br J Ophthalmol 84:1372–1375, 2000

108. Yanagi Y, Iriyama A, Jang WD, Kadonosono K: Evaluation of the safety of xenon/bandpass light in vitrectomy using the A2E-laden RPE model. Graefes Arch Clin Exp Ophthalmol 245:677–681, 2007

109. DaMata AP, Riemann CD, Nehemy MB et al: Indocyanine green-assisted internal limiting membrane peeling for macular holes: to stain or not to stain? Retina 25:395–404, 2005

110. Hillenkamp J, Saikia P, Gora F et al: Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green. Br J Ophthalmol 89:437–443, 2005

111. Baumler W, Abels C, Karrer S et al: Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer 80:360–363, 1999

112. Fickweiler S, Szeimies RM, Baumler W et al: Indocyanine green: Intracellular uptake and phototherapeutic effects in vitro. J Photochem Photobiol 38:178–183, 1997

113. Saikia P, Maisch T, Kobuch K et al: Safety testing of indocyanine green in an ex vivo porcine retina model. Invest Ophthalmol Vis Sci 47:4998–5003, 2006

114. Yip HK, Lai TY, So KF, Kwok AK. Retinal ganglion cells toxicity caused by photosensitizing effects of intravitreal indocyanine green with illumination in rat eyes. Br J Ophthalmol 90:99–102, 2006

21 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

115. Narayanan R, Kenney MC, Kamjoo S et al: Toxicity of indocyanine green (ICG) in combination with light on retinal pigment epithelial cells and neurosensory retinal cells. Curr Eye Res 30:471–478, 2005

116. Kwok AK, Lai TY, Yeung CK et al: The effects of indocyanine green and endoillumination on rabbit retina: An electroretinographic and histological study. Br J Ophthalmol 89:897–900, 2005

117. Mavrofrides E, Smiddy WE, Kitchens JW et al: Indocyanine green-assisted internal limiting membrane peeling for macular holes: toxicity? Retina 26:637–644, 2006

118. van der Hoeve J: Eye lesions produced by light rich in ultraviolet rays: Senile cataract, senile degeneration of the macula. Am J Ophthalmol 3:178, 1920

119. Sperduto RD, Hiller R, Seigel D: Lens opacities and senile maculopathy. Arch Ophthalmol 99:1004, 1981

120. Chumbley LC: Impressions of eye diseases among Rhodesian blacks in Marshonland. S Afr Med J 52:316, 1977

121. Gregor Z, Joffe L: Senile macular changes in the black African. Br J Ophthalmol 62:554, 1978

122. Maltzman BA, Mulvihill MN, Greenbaum A: Senile macular degeneration and risk factors: A case control study. Ann Ophthalmol 11:1197, 1979

123. Hyman LG, Lilienfeld AM, Ferris FL III et al: Senile macular degeneration: A case control study. Am J Epidemiol 118:213, 1983

124. Weiter JJ, Delori FC, Wing GL et al: Relationship of senile macular degeneration to ocular pigmentation. Am J Ophthalmol 99:185, 1985

125. Holz FG, Piquet B, Minassian DC et al: Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration. Am J Ophthalmol 117:19, 1994

126. Sandberg MA, Gaudio AR, Miller S et al: Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 35:2734, 1994

127. La Vail MM: Eye pigmentation and constant light damage in the rat retina. In Williams TP, Baker BN (eds): The Effects of Constant Light on Visual Processes. New York: Plenum, 1980:357–387

128. Penn JS, Howard AG, Williams TP: Light damage as a function of “light history” in the albino rat. In La Vail MM, Hollyfield JG, Anderson RE (eds): Retinal Degeneration: Experimental and Clinical Studies. New York: Alan R Liss, 1985:439–447

129. Rapp LM, Williams TP: A parametric study of retinal light damage in albino and pigmented rats. In Williams TP, Baker BN (eds): The Effects of Constant Light on Visual Processes. New York: Plenum

22 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

Publishing, 1980:135–139

130. Taylor HR, Munoz B, West S et al: Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc 88:163, 1990

131. Taylor HR, Munoz B, West S et al: The long-term effects of visible light on the eye. Arch Ophthalmol 110:99, 1992

132. The Case-Control Study Group: Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701–1708, 1992

133. Hirvela H, Luukinen H, Laara E et al: Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103:871–877, 1996

134. Darzins P, Mithcell P, Heller RF: Sun exposure and age-related macular degeneration: An Australian case-control study. Ophthalmology 104:770–776, 1997

135. McCarty CA, Mukesh BN, Fu CL et al: Risk factors for age-related maculopathy: The Project. Arch Ophthalmol 119:1455–1462, 2001

136. Delcourt C, Carrier I, Ponton-Sanchez A et al: Light exposure and the risk of age-related macular degeneration: The Pathologies Oculaires Liees a l'Age (POLA) study. Arch Ophthalmol 119:1463–1468, 2001

137. Tomany SC, Cruickshanks KJ, Klein R et al: Sunlight and the 10-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Arch Ophthalmol 122:750–757, 2004

138. Clemons TE, Milton RC, Klein R et al: Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no 19. Ophthalmology 112:533–539, 2005

139. Freeman EE, Munoz B, West SK et al: Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol 135:849–856, 2003

140. Libre PE: Intraoperative light toxicity: A possible explanation for the association between cataract surgery and age-related macular degeneration. Am J Ophthalmol 136:961, 2003

141. Patz A, Hoeck LE, DeLaCruz E: Studies on the effect of high oxygen administration in retrolental fibroplasia: Nursery observations. Am J Ophthalmol 35:1248, 1952

142. Glass P: Light and the developing retina. Doc Ophthalmol 74:195, 1990

143. Glass P, Avery GB, Subramanian KN et al: Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity. N Engl J Med 313:401, 1985

23 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

144. Reynolds JD, Hardy RJ, Kennedy KA et al: Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med 338:1572–1576, 1998

145. Katz ML, Robinson WG Jr: Autoxidative damage to the retina: Potential role in retinopathy of prematurity. In Flynn JT, Phelps DL (eds): Retinopathy of Prematurity: Problem and Challenge. New York: Alan R Liss, 1988:237–248

146. Riley PA, Slater TF: Pathogenesis of retrolental fibroplasia. Lancet ii:265, 1969

147. Nielson JC, Naash MI, Anderson RE: The regional distribution of vitamins E and C in mature and premature human retinas. Invest Ophthalmol Vis Sci 29:22, 1988

148. Penn JS, Thum LA, Naash MI: Oxygen-induced retinopathy in the rat: Vitamins C and E as potential therapies. Invest Ophthalmol Vis Sci 33:1636, 1992

149. Calkins JL, Hochheimer BF: Retinal light exposure from operating microscopes. Arch Ophthalmol 97:2363, 1979

150. Jampol LM: Aphakic cystoid macular edema: A hypothesis. Arch Ophthalmol 103:1134, 1985

151. Jampol LM, Kraff MC, Sanders DR et al: Near UV radiation from the operating microscope and pseudophakic cystoid macular edema. Arch Ophthalmol 103:28, 1985

152. Iliff WJ: Aphakic cystoid macular edema and the operating microscope: Is there a connection? Trans Am Ophthalmol Soc 83:476, 1985

153. Kraff MC, Sanders DR, Jampol LM et al: Effect of an ultraviolet filtering intraocular lens on cystoid macular edema. Ophthalmology 92:366, 1985

154. Absolon MJ: The effects of ultraviolet light on the eye. Trans Ophthalmol Soc UK 104:522, 1985

155. Tucker MA, Shields JA, Hartge P et al: Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 313(13):789–792, 1985

156. Seddon JM, Gragoudas ES, Glynn RJ et al: Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol 108(9):1274–1280, 1990

157. Pane AR, Hirst LW. Ultraviolet light exposure as a risk factor for ocular melanoma in Queensland, Australia. Ophthalmic Epidemiol 7(3):159–167, 2000

158. Holly EA, Aston DA, Char DH et al: Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res 15;50(18):5773–5777, 1990

159. Guenel P, Laforest L, Cyr D et al: Occupational risk factors, ultraviolet radiation, and ocular

24 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

melanoma: A case-control study in France. Cancer Causes Control 12(5):451–459, 2001

160. Lutz JM, Cree I, Sabroe S et al: Occupational risks for uveal melanoma results from a case-control study in nine European countries. Cancer Causes Control 16(4):437–447, 2005

161. Shah CP, Weis E, Lajous M et al: Intermittent and chronic ultraviolet light exposure and uveal melanoma: A meta-analysis. Ophthalmology 112(9):1599–1607, 2005

162. Singh AD, Rennie IG, Seregard S et al: Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 49(4):419–428, 2004

163. Dolin PJ, Foss AJ, Hungerford JL: Uveal melanoma: Is solar ultraviolet radiation a risk factor? Ophthalmic Epidemiol 1(1):27–30, 1994

164. Green WR, Robertson DM: Pathologic findings of photic retinopathy in the human eye. Am J Ophthalmol 112:520, 1991

165. Parver LM, Auker CR, Fine BS: Observations on monkey eyes exposed to light from an operating microscope. Ophthalmology 90:964, 1983

166. Jaffe GJ, Irvine AR, Wood IS et al: Retinal phototoxicity from the operating microscope: The role of inspired oxygen. Ophthalmology 95:1130, 1988

167. Mainster MA: Spectral transmittance of intraocular lenses and retinal damage from intense light sources. Am J Ophthalmol 85:167, 1978

168. Lerman S: Radiant Energy and the Eye. New York: Macmillan, 1980

169. Mainster MA: Violet and blue light blocking intraocular lenses: Photoprotection versus photoreception. Br J Ophthalmol 90:784–792, 2006

170. Lerman S: Parker Heath Memorial Lecture: Photosensitizing drugs and their possible role in enhancing ocular toxicity. Ophthalmology 93:304, 1986

171. Clarke CA, Sneddon IB: Nutritional neuropathy in prisoners-of-war and internees from Hong-Kong. Lancet i:734, 1946

172. American National Standard: Requirements for nonprescription sunglasses and fashion eyewear. New York: American National Standards Institute, 1986

173. Borgwardt B, Fishman GA, VanderMeulen D: Spectral transmission characteristics of tinted lenses. Arch Ophthalmol 99:293, 1981

174. Fishman GA: Ocular phototoxicity: Guidelines for selecting sunglasses. Surv Ophthalmol 31:119, 1986

25 de 26 29/04/2013 15:58 Ovid: Duane's Ophthalmology http://ovidsp.tx.ovid.com/sp-3.8.1a/ovidweb.cgi

175. Schwartz LK, Norris JL: A corneal shield to prevent light-induced maculopathy during cataract surgery. Am J Ophthalmol 97:658, 1984

176. McIntyre DJ: Phototoxicity: The eclipse filter. Ophthalmology 92:364, 1985

177. Nevyas HJ, Nevyas JY: Surgical corneal light occluder made of black hema. Ophthalmic Surg 16:696, 1985

178. Yanoff M, Kurata F, Lamensdorf M: Inexpensive device to reduce surgical light exposure. Ophthalmology 90(Suppl):137, 1983

179. Urinowski E, Cahane M, Ashkenazi I et al: Proximity-sensor dimmer device as an aid in the reduction of operating microscope-induced retinal phototoxicity. Ophthalmic Surg 25:122, 1994

180. Braunstein RE, Sparrow JR: A blue-blocking intraocular lens should be used in cataract surgery. Arch Ophthalmol 123:547–549, 2005

181. Mainster MA: Intraocular lenses should block UV radiation but not blue light. Arch Ophthalmol 123:550–555, 2005

26 de 26 29/04/2013 15:58